Product Code: GVR-4-68040-424-4
Offsite Sterilization Services Market Growth & Trends:
The global offsite sterilization services market size is anticipated to reach USD 3.47 billion by 2030 and is projected to grow at a CAGR of 7.05% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market encompasses a range of services and technologies designed to sterilize medical devices, pharmaceuticals, and food products outside the primary manufacturing or healthcare facilities. This market is critical for ensuring products are free from viable microorganisms, thus maintaining safety and compliance with health regulations.
Advancements in medical technology and an aging population drive the increasing number of surgical procedures being conducted worldwide. This trend is accompanied by a growing prevalence of chronic diseases that necessitate surgical treatment.
Technological advancements in sterilization methods are also a key driver for this market. Innovations such as ethylene oxide (EtO) gas sterilization, hydrogen peroxide vaporization, and steam sterilization techniques enhanced efficiency and effectiveness in achieving sterility. Advanced technologies can significantly shorten cycle times while ensuring high sterility assurance levels.
Offsite Sterilization Services Market Report Highlights:
- Based on services, the ethylene oxide (EtO) sterilization segment led the market with the largest revenue share of in 2023. The rising prevalence of chronic diseases that often require surgical intervention. As the global population ages and the number of surgical procedures increases, the demand for effective sterilization methods becomes more pronounced.
- Based on end use, the medical device companies segment led the market with the largest revenue share of 45.76% in 2023.Medical device manufacturers rely on offsite sterilization services to ensure the thorough decontamination of their products, particularly surgical instruments and implantable devices. This is critical in preventing infections and enhancing patient outcomes.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Service
- 1.2.2. End Use
- 1.2.3. Regional scope
- 1.2.4. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Service Outlook
- 2.2.2. End Use Outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Offsite Sterilization Service Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing Demand for Infection Control
- 3.2.1.2. Advancements in Sterilization Technologies
- 3.2.1.3. Regulatory Pressures for Patient Safety
- 3.2.2. Market restraint analysis
- 3.2.2.1. High cost of services
- 3.2.2.2. Regulatory challenges
- 3.3. Offsite Sterilization Service Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
Chapter 4. Offsite Sterilization Service Market: Services Estimates & Trend Analysis
- 4.1. Global Offsite Sterilization Service Market: Services Dashboard
- 4.2. Global Offsite Sterilization Service Market: Services Movement Analysis
- 4.3. Global Offsite Sterilization Service Market by Services, Revenue
- 4.4. Ethylene oxide sterilization
- 4.4.1. Ethylene oxide sterilization market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5. Gamma sterilization
- 4.5.1. Gamma sterilization market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6. Electron beam sterilization
- 4.6.1. Electron beam sterilization market estimates and forecasts 2018 to 2030 (USD Million)
- 4.7. Steam sterilization
- 4.7.1. Steam sterilization market estimates and forecasts 2018 to 2030 (USD Million)
- 4.8. No2 sterilization
- 4.8.1. No2 sterilization market estimates and forecasts 2018 to 2030 (USD Million)
- 4.9. Other
- 4.9.1. Other market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Offsite Sterilization Service Market: End Use Estimates & Trend Analysis
- 5.1. Global Offsite Sterilization Service Market: End Use Dashboard
- 5.2. Global Offsite Sterilization Service Market: End Use Movement Analysis
- 5.3. Global Offsite Sterilization Service Market Estimates and Forecasts, By End Use, Revenue (USD Million)
- 5.4. Hospitals
- 5.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5. Clinics
- 5.5.1. Clinics market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6. Medical device companies
- 5.6.1. Medical device companies market estimates and forecasts 2018 to 2030 (USD Million)
- 5.7. Pharmaceutical companies
- 5.7.1. Pharmaceutical companies market estimates and forecasts 2018 to 2030 (USD Million)
- 5.8. Other
- 5.8.1. Other market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Offsite Sterilization Service Market: Regional Estimates & Trend Analysis by Services, and End Use
- 6.1. Regional Dashboard
- 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 6.3. North America
- 6.3.1. U.S.
- 6.3.1.1. Key country dynamics
- 6.3.1.2. Regulatory framework/ reimbursement structure
- 6.3.1.3. Competitive scenario
- 6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 6.3.2. Canada
- 6.3.2.1. Key country dynamics
- 6.3.2.2. Regulatory framework/ reimbursement structure
- 6.3.2.3. Competitive scenario
- 6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 6.3.3. Mexico
- 6.3.3.1. Key country dynamics
- 6.3.3.2. Regulatory framework/ reimbursement structure
- 6.3.3.3. Competitive scenario
- 6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4. Europe
- 6.4.1. UK
- 6.4.1.1. Key country dynamics
- 6.4.1.2. Regulatory framework/ reimbursement structure
- 6.4.1.3. Competitive scenario
- 6.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.2. Germany
- 6.4.2.1. Key country dynamics
- 6.4.2.2. Regulatory framework/ reimbursement structure
- 6.4.2.3. Competitive scenario
- 6.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.3. France
- 6.4.3.1. Key country dynamics
- 6.4.3.2. Regulatory framework/ reimbursement structure
- 6.4.3.3. Competitive scenario
- 6.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.4. Italy
- 6.4.4.1. Key country dynamics
- 6.4.4.2. Regulatory framework/ reimbursement structure
- 6.4.4.3. Competitive scenario
- 6.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.5. Spain
- 6.4.5.1. Key country dynamics
- 6.4.5.2. Regulatory framework/ reimbursement structure
- 6.4.5.3. Competitive scenario
- 6.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.6. Norway
- 6.4.6.1. Key country dynamics
- 6.4.6.2. Regulatory framework/ reimbursement structure
- 6.4.6.3. Competitive scenario
- 6.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.7. Sweden
- 6.4.7.1. Key country dynamics
- 6.4.7.2. Regulatory framework/ reimbursement structure
- 6.4.7.3. Competitive scenario
- 6.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.8. Denmark
- 6.4.8.1. Key country dynamics
- 6.4.8.2. Regulatory framework/ reimbursement structure
- 6.4.8.3. Competitive scenario
- 6.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5. Asia Pacific
- 6.5.1. Japan
- 6.5.1.1. Key country dynamics
- 6.5.1.2. Regulatory framework/ reimbursement structure
- 6.5.1.3. Competitive scenario
- 6.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.2. China
- 6.5.2.1. Key country dynamics
- 6.5.2.2. Regulatory framework/ reimbursement structure
- 6.5.2.3. Competitive scenario
- 6.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.3. India
- 6.5.3.1. Key country dynamics
- 6.5.3.2. Regulatory framework/ reimbursement structure
- 6.5.3.3. Competitive scenario
- 6.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.4. Australia
- 6.5.4.1. Key country dynamics
- 6.5.4.2. Regulatory framework/ reimbursement structure
- 6.5.4.3. Competitive scenario
- 6.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.5. South Korea
- 6.5.5.1. Key country dynamics
- 6.5.5.2. Regulatory framework/ reimbursement structure
- 6.5.5.3. Competitive scenario
- 6.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.6. Thailand
- 6.5.6.1. Key country dynamics
- 6.5.6.2. Regulatory framework/ reimbursement structure
- 6.5.6.3. Competitive scenario
- 6.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6. Latin America
- 6.6.1. Brazil
- 6.6.1.1. Key country dynamics
- 6.6.1.2. Regulatory framework/ reimbursement structure
- 6.6.1.3. Competitive scenario
- 6.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.2. Argentina
- 6.6.2.1. Key country dynamics
- 6.6.2.2. Regulatory framework/ reimbursement structure
- 6.6.2.3. Competitive scenario
- 6.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7. MEA
- 6.7.1. South Africa
- 6.7.1.1. Key country dynamics
- 6.7.1.2. Regulatory framework/ reimbursement structure
- 6.7.1.3. Competitive scenario
- 6.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.2. Saudi Arabia
- 6.7.2.1. Key country dynamics
- 6.7.2.2. Regulatory framework/ reimbursement structure
- 6.7.2.3. Competitive scenario
- 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.3. UAE
- 6.7.3.1. Key country dynamics
- 6.7.3.2. Regulatory framework/ reimbursement structure
- 6.7.3.3. Competitive scenario
- 6.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.4. Kuwait
- 6.7.4.1. Key country dynamics
- 6.7.4.2. Regulatory framework/ reimbursement structure
- 6.7.4.3. Competitive scenario
- 6.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Company/Competition Categorization
- 7.2. Vendor Landscape
- 7.2.1. List of key distributors and channel partners
- 7.2.2. Key company market share analysis, 2023
- 7.2.3. STERIS
- 7.2.3.1. Company overview
- 7.2.3.2. Financial performance
- 7.2.3.3. Product benchmarking
- 7.2.3.4. Strategic initiatives
- 7.2.4. Sotera Health
- 7.2.4.1. Company overview
- 7.2.4.2. Financial performance
- 7.2.4.3. Product benchmarking
- 7.2.4.4. Strategic initiatives
- 7.2.5. CRETEX Medical
- 7.2.5.1. Company overview
- 7.2.5.2. Financial performance
- 7.2.5.3. Product benchmarking
- 7.2.5.4. Strategic initiatives
- 7.2.6. Scapa
- 7.2.6.1. Company overview
- 7.2.6.2. Financial performance
- 7.2.6.3. Product benchmarking
- 7.2.6.4. Strategic initiatives
- 7.2.7. BGS Beta-Gamma-Service GmbH & Co. KG
- 7.2.7.1. Company overview
- 7.2.7.2. Financial performance
- 7.2.7.3. Product benchmarking
- 7.2.7.4. Strategic initiatives
- 7.2.8. E-BEAM Services, Inc.
- 7.2.8.1. Company overview
- 7.2.8.2. Financial performance
- 7.2.8.3. Product benchmarking
- 7.2.8.4. Strategic initiatives
- 7.2.9. Medistri SA
- 7.2.9.1. Company overview
- 7.2.9.2. Financial performance
- 7.2.9.3. Product benchmarking
- 7.2.9.4. Strategic initiatives
- 7.2.10. Midwest Sterilization Corporation
- 7.2.10.1. Company overview
- 7.2.10.2. Financial performance
- 7.2.10.3. Product benchmarking
- 7.2.10.4. Strategic initiatives
- 7.2.11. Microtrol Sterilization Services Pvt. Ltd.
- 7.2.11.1. Company overview
- 7.2.11.2. Financial performance
- 7.2.11.3. Product benchmarking
- 7.2.11.4. Strategic initiatives
- 7.2.12. ClorDiSys Solutions Inc.
- 7.2.12.1. Company overview
- 7.2.12.2. Financial performance
- 7.2.12.3. Product benchmarking
- 7.2.12.4. Strategic initiatives